NCT03813303 (CPART) is a Phase 4 clinical trial of Midazolam in Colonoscopy, sponsored by Federal University of Minas Gerais.

Who is sponsoring NCT03813303?

NCT03813303 is sponsored by Federal University of Minas Gerais.

What drugs are being tested in NCT03813303?

Interventions in NCT03813303: Midazolam, Fentanyl, Propofol.

What condition does NCT03813303 study?

NCT03813303 studies Colonoscopy, Anesthesia.

Is NCT03813303 still recruiting?

NCT03813303 is currently completed. Last updated 23 January 2019.

Last reviewed 2019-01-23 · How we verify

NCT03813303: CPART

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Post Anesthetic Recovery Time in Sedated Patients for Colonoscopy

Completed Phase 4 Last updated 23 January 2019

What this trial tests

Phase 4 trial testing Midazolam in Colonoscopy in 50 participants. Completed in 25 June 2018.

Timeline

20 March 2018

Primary endpoint
25 June 2018

25 June 2018

Quick facts

Lead sponsor	Federal University of Minas Gerais
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	50
Start date	20 March 2018
Primary completion	25 June 2018
Estimated completion	25 June 2018
Sites	1 location across Brazil

Drugs / interventions tested

Midazolam (midazolam) — full drug profile →
Fentanyl (fentanyl) — full drug profile →
Propofol (Propofol) — full drug profile →

Conditions studied

Colonoscopy — all drugs for Colonoscopy →
Anesthesia — all drugs for Anesthesia →

Sponsor

Federal University of Minas Gerais

Who can join

18 and older, any sex, with Colonoscopy or Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Colonoscopy is an important diagnostic and therapeutic tool in colon disorders. Different drugs and levels of sedation can be used in its accomplishment. There is no consensus on which is the ideal. The aim of this study was to compare the post anesthetic recovery time between patients deeply sedated with midazolam and propofol or fentanyl and propofol. 50 American Society of Anesthesiologist physical state (ASA) I and II candidates elective colonoscopy at Luxembourg Hospital were divided into two groups A) midazolam and propofol or B) fentanyl and propofol. Time of examination, post anesthetic recovery and discharge at home, intercurrence and propofol consumption were compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Midazolam

Trials testing the same drug.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT07525544 — A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants · Phase 1 · not yet recruiting
NCT07426757 — An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers · Phase 1 · not yet recruiting
NCT07435194 — A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazo · Phase 1 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other recruiting trials for Colonoscopy

Currently open trials in the same condition.

NCT07353853 — Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease · NA · recruiting
NCT07335705 — Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients · recruiting
NCT06763705 — Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy · Phase 4 · recruiting
NCT07171853 — The Carbon Footprint Study of Colonoscopy · recruiting
NCT07355777 — Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation · NA · recruiting

Other Federal University of Minas Gerais trials

Trials by the same sponsor.

NCT07310979 — Clinical Evaluation of a Hyperbolic Paraboloid Triple-Abutment on Morse Taper Dental Implants · enrolling by invitation
NCT07479875 — Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes · NA · completed
NCT06916988 — Modified and Context-Focused Sports Intervention in Adolescents With Autism: Study Protocol · NA · recruiting
NCT06764342 — Adjunctive Effect of Photodynamic Therapy on Halitosis · NA · completed
NCT06646523 — Effects of Home-based High-speed Bodyweight Resistance Training in Individual With Parkinson's Disease · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03813303 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Federal University of Minas Gerais
Last refreshed: 23 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03813303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing